IBDEI0YQ ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17253,2)
 ;;=^336873
 ;;^UTILITY(U,$J,358.3,17254,0)
 ;;=208.81^^111^1077^37
 ;;^UTILITY(U,$J,358.3,17254,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17254,1,1,0)
 ;;=1^208.81
 ;;^UTILITY(U,$J,358.3,17254,1,8,0)
 ;;=8^Oth Leuk Unspec Cell Type w/ Rem
 ;;^UTILITY(U,$J,358.3,17254,2)
 ;;=^267574
 ;;^UTILITY(U,$J,358.3,17255,0)
 ;;=208.82^^111^1077^36
 ;;^UTILITY(U,$J,358.3,17255,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17255,1,1,0)
 ;;=1^208.82
 ;;^UTILITY(U,$J,358.3,17255,1,8,0)
 ;;=8^Oth Leuk Unspec Cell Type in Relap
 ;;^UTILITY(U,$J,358.3,17255,2)
 ;;=^336488
 ;;^UTILITY(U,$J,358.3,17256,0)
 ;;=209.00^^111^1077^25
 ;;^UTILITY(U,$J,358.3,17256,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17256,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,17256,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Sm Intestine
 ;;^UTILITY(U,$J,358.3,17256,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,17257,0)
 ;;=209.01^^111^1077^22
 ;;^UTILITY(U,$J,358.3,17257,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17257,1,1,0)
 ;;=1^209.01
 ;;^UTILITY(U,$J,358.3,17257,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Duodenum
 ;;^UTILITY(U,$J,358.3,17257,2)
 ;;=^336490
 ;;^UTILITY(U,$J,358.3,17258,0)
 ;;=209.02^^111^1077^24
 ;;^UTILITY(U,$J,358.3,17258,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17258,1,1,0)
 ;;=1^209.02
 ;;^UTILITY(U,$J,358.3,17258,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Jejunum
 ;;^UTILITY(U,$J,358.3,17258,2)
 ;;=^336491
 ;;^UTILITY(U,$J,358.3,17259,0)
 ;;=209.03^^111^1077^23
 ;;^UTILITY(U,$J,358.3,17259,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17259,1,1,0)
 ;;=1^209.03
 ;;^UTILITY(U,$J,358.3,17259,1,8,0)
 ;;=8^Mal Carcinoid Tumor,Ileum
 ;;^UTILITY(U,$J,358.3,17259,2)
 ;;=^336492
 ;;^UTILITY(U,$J,358.3,17260,0)
 ;;=204.00^^111^1078^1
 ;;^UTILITY(U,$J,358.3,17260,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17260,1,1,0)
 ;;=1^204.00
 ;;^UTILITY(U,$J,358.3,17260,1,8,0)
 ;;=8^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,17260,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,17261,0)
 ;;=204.01^^111^1078^3
 ;;^UTILITY(U,$J,358.3,17261,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17261,1,1,0)
 ;;=1^204.01
 ;;^UTILITY(U,$J,358.3,17261,1,8,0)
 ;;=8^ALL,in Remission
 ;;^UTILITY(U,$J,358.3,17261,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,17262,0)
 ;;=204.10^^111^1078^5
 ;;^UTILITY(U,$J,358.3,17262,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17262,1,1,0)
 ;;=1^204.10
 ;;^UTILITY(U,$J,358.3,17262,1,8,0)
 ;;=8^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,17262,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,17263,0)
 ;;=204.11^^111^1078^7
 ;;^UTILITY(U,$J,358.3,17263,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17263,1,1,0)
 ;;=1^204.11
 ;;^UTILITY(U,$J,358.3,17263,1,8,0)
 ;;=8^CLL,in Remission
 ;;^UTILITY(U,$J,358.3,17263,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,17264,0)
 ;;=201.90^^111^1078^11
 ;;^UTILITY(U,$J,358.3,17264,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17264,1,1,0)
 ;;=1^201.90
 ;;^UTILITY(U,$J,358.3,17264,1,8,0)
 ;;=8^Hodgkin's Lymphoma,Unspec Type
 ;;^UTILITY(U,$J,358.3,17264,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,17265,0)
 ;;=202.00^^111^1078^19
 ;;^UTILITY(U,$J,358.3,17265,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17265,1,1,0)
 ;;=1^202.00
 ;;^UTILITY(U,$J,358.3,17265,1,8,0)
 ;;=8^Lymphoma,Low-Grade (Nodular)
 ;;^UTILITY(U,$J,358.3,17265,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,17266,0)
 ;;=200.20^^111^1078^16
 ;;^UTILITY(U,$J,358.3,17266,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,17266,1,1,0)
 ;;=1^200.20
 ;;^UTILITY(U,$J,358.3,17266,1,8,0)
 ;;=8^Lymphoma,Burkitts
 ;;^UTILITY(U,$J,358.3,17266,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,17267,0)
 ;;=202.10^^111^1078^29
